Market Cap

CanSino Biologics, Inc. Market Capitalization:

CN¥10.57 Billion

CNY as of Jan. 1, 2024

US$1.49 Billion

business CanSino Biologics, Inc. Company Profile

CanSino Biologics, Inc. Main Stock Listing

SSE: 688185

Market Capitalization History of CanSino Biologics, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
Zoetis Inc. $89.09 B
MERCK Kommanditgesellschaft auf Aktien $67.64 B
Takeda Pharmaceutical Company Limited $47.71 B
Haleon plc $38.90 B
PPD, Inc. $16.58 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of CanSino Biologics, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2024 CN¥10.57 B -55.65%
Jan. 1, 2023 CN¥23.83 B -41.54%
Jan. 1, 2022 CN¥40.76 B -28.81%
Jan. 1, 2021 CN¥57.25 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +313.24%

$10,000 in May 2023 would now be $41,324 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

CanSino Biologics, Inc. Categories

China languages Healthcare languages Drug Manufacturers—Specialty & Generic
China Healthcare China Drug Manufacturers—Specialty & Generic

Stocks & Indices

CanSino Biologics, Inc. has the following listings and related stock indices.


Stock: SSE: 688185

Stock: FSX: CJH

Stock: HKEX: 6185

Stock: OTC: CASBF

Stock: XSTU: CJH

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.